Insulin aspart, recombinant Subcutaneous and Prevacid Naprapac
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Prevacid Naprapac and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: lansoprazole / naproxen
Brand name: Prevacid NapraPAC 500
Synonyms: Prevacid NapraPAC
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Prevacid OTC
- Insulin aspart, recombinant Subcutaneous-Prevacid SoluTab
- Insulin aspart, recombinant Subcutaneous-Prevalite
- Insulin aspart, recombinant Subcutaneous-Preven EC
- Insulin aspart, recombinant Subcutaneous-Prevex Hc Topical application
- Insulin aspart, recombinant Subcutaneous-Previfem
- Prevacid Naprapac-Insulin degludec
- Prevacid Naprapac-Insulin Degludec (U-100) Prefilled Pens
- Prevacid Naprapac-Insulin Degludec (U-100) Vials
- Prevacid Naprapac-Insulin Degludec (U-200) Prefilled Pens
- Prevacid Naprapac-Insulin degludec and liraglutide
- Prevacid Naprapac-Insulin degludec and liraglutide Subcutaneous